The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold?

This is a generated summary. It shows the 5 most-liked posts from a topic of 24, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
AR
a.reyesTL4 Admin6 Nov 2024#1

TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked.

Two things I would like separated before anyone answers on TB-500 and thymosin beta-4, because they get bundled and then argued about as one thing.

The first is descriptive: what has actually been observed, by whom, and how. The second is causal: why. I am asking about the first only.

38 likes 21mo
FR
f.rasmussenTL221 Nov 2024#6

Where I part company with post #2, and it is a narrow parting.

Two questions I would want answered before drawing anything from the TB-500 and thymosin beta-4 data above: how were the cases selected, and what happened to the ones that dropped out.

29 likes 20mo
CH
ca.haddadTL211 Dec 2024#16
priorauth_notes, post #7: The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well characterised. Adding it in case it saves somebody the afternoon it cost me. Go to post

Post #13 is right about the mechanism and I think understates the practical bit.

The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was made and how it travelled.

That is a description of practice, not a recommendation of it.

26 likes in reply to #7 20mo
SC
s.cardosoTL218 Dec 2024#20

Building on post #17 rather than restating it.

Where I have landed on TB-500 and thymosin beta-4, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.

19 likes 19mo
PW
PharmNotes_WhitfieldTL4Pharmacist25 Dec 2024#24

This is the answer, and the reason it is the answer is the more useful part.

26 likes 19mo

Read the full topic (24 posts)

This topic was closed 60 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.

Suggested topics

TopicParticipantsRepliesViewsActivity
What would change my mind about repair peptides: a specific answer — one year on
What would change my mind about repair peptides: a specific answer — one year on I have a specific reason for asking rather than idle curiosity, and the context is below. Documentation question rather than a…
CTLLFVON+9 13 42k 19mo
Why the absence of controlled human data on BPC-157 matters more than people admit
Why the absence of controlled human data on BPC-157 matters more than people admit — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to know what people…
CMVMPFNBHF+60 66 16k 1d
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about…
FAKLSLAS+50 55 7.8k 2d
BPC-157: what the rodent literature actually shows, and what it does not — does this still hold?
The question in the title: BPC-157: what the rodent literature actually shows, and what it does not — does this still hold? I will give what I have already checked below so nobody repeats it. I would like to…
ASBSMCSBLS+6 10 3.1k 1d
BPC-157: what the rodent literature actually shows, and what it does not — a second dataset
On the subject in the title: BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Working notes rather than a conclusion. The question about BPC-157 that I actually want…
WNCDSOOSB+77 84 54k 11mo

Related topics — sharing the tags TB-500, BPC-157, needs a source

TopicParticipantsRepliesViewsActivity
Sequence verification for an obscure compound: how it is done
Sequence verification for an obscure compound: how it is done Writing it up because I had to work it out twice and would rather nobody else did. Asking about sequence verification directly, because I have…
BNGVIAJVGE+104 114 10k 12mo
CJC-1295 with and without DAC: what the modification does
On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Putting the numbers in the first post, because a question about a compound…
MSNCDHEHNE+117 123 5.6k 22h
A preprint whose numbers changed substantially at publication
A preprint whose numbers changed substantially at publication — setting out what I have, and where I think it stops being reliable. A preprint question rather than a question about the finding in it. The…
IBCNNDBRC+90 95 21k 9mo
A widely repeated interaction claim that turns out to be unsupported
On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. I was wrong about widely repeated interaction claim in a thread last…
NKRGBNMSDT+47 51 37k 3mo
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on
On the subject in the title: Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Working notes rather than a conclusion. A follow-up question about Delayed gastric…
MAKSVCD 3 16k 2mo